No Data
Cumberland Pharmaceuticals (CPIX.US) will release its financial report after the market closes on November 7th.
Cumberland Pharmaceuticals (CPIX.US) will release its earnings report after the market closes on November 7th. How was its previous performance? For 2024 Q2, revenue was $9.848849 million, net income was -$-1.102637 million, and eps was -$0.08. For 2023 Q3, revenue was $10.085926 million, net income was -$-1.063219 million, and eps was -$0.07. The above data is presented in accordance with US GAAP. Futubull reminder: 1. Hong Kong stocks, US
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS
Earnings Call Summary | Cumberland Pharmaceuticals(CPIX.US) Q2 2024 Earnings Conference
Cumberland Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Cumberland Q2 Adj $0.01 Down From $0.16 YoY, Sales $9.85M Down From $10.89M YoY
Express News | Cumberland Pharmaceuticals Inc - on Track to Post Significant Revenue Growth and Positive Cashflow From Operations During 2024